Skvarka Jan

CIK 00018380423 companiesBOSTON, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001838042

Recent Transactions

27 trades

Award
Zentalis Pharmaceuticals, Inc.$ZNTL
Common Stock
2025-06-17+57,603→ 207,154 total
Award
Monte Rosa Therapeutics, Inc.$GLUE
Stock Option (Right to Buy)
2025-06-13+30,700→ 30,700 total
Purchase
Zentalis Pharmaceuticals, Inc.$ZNTL
Common Stock
2025-01-31$1.72/sh+60,000→ 149,551 total
Award
Zentalis Pharmaceuticals, Inc.$ZNTL
Common Stock
2024-06-21+41,581→ 89,551 total
Award
Monte Rosa Therapeutics, Inc.$GLUE
Stock Option (Right to Buy)
2024-06-12+22,100→ 22,100 total
Sale
Zentalis Pharmaceuticals, Inc.$ZNTL
Common Stock
2023-09-11$25.05/sh−5,000→ 47,970 total
Award
Zentalis Pharmaceuticals, Inc.$ZNTL
Common Stock
2023-06-16+16,364→ 52,970 total
Award
Monte Rosa Therapeutics, Inc.$GLUE
Stock Option (Right to Buy)
2023-06-14+20,500→ 20,500 total
Award
Monte Rosa Therapeutics, Inc.$GLUE
Stock Option (Right to Buy)
2023-03-30+41,000→ 41,000 total
Award
Zentalis Pharmaceuticals, Inc.$ZNTL
Common Stock
2022-09-09+36,606→ 36,606 total
Disposition to Issuer
Trillium Therapeutics Inc.
Stock Option (Right to Buy)
2021-11-17−1,162,500→ 0 total
Disposition to Issuer
Trillium Therapeutics Inc.
Stock Option (Right to Buy)
2021-11-17−600,000→ 0 total
Disposition to Issuer
Trillium Therapeutics Inc.
Stock Option (Right to Buy)
2021-11-17−197,000→ 0 total
Sale
Trillium Therapeutics Inc.
Common Shares
2021-05-12$9.24/sh−23,802→ 0 total
Exercise/Conversion
Trillium Therapeutics Inc.
Stock Option (Right to Buy)
2021-05-12−23,802→ 197,000 total
Exercise/Conversion
Trillium Therapeutics Inc.
Common Shares
2021-05-12$0.31/sh+23,802→ 23,802 total
Exercise/Conversion
Trillium Therapeutics Inc.
Common Shares
2021-05-11$0.31/sh+19,198→ 106,698 total
Exercise/Conversion
Trillium Therapeutics Inc.
Stock Option (Right to Buy)
2021-05-11−19,198→ 220,802 total
Exercise/Conversion
Trillium Therapeutics Inc.
Stock Option (Right to Buy)
2021-05-11−87,500→ 1,162,500 total
Exercise/Conversion
Trillium Therapeutics Inc.
Common Shares
2021-05-11$0.45/sh+87,500→ 87,500 total
Sale
Trillium Therapeutics Inc.
Common Shares
2021-05-11$9.20/sh−106,698→ 0 total
Sale
Trillium Therapeutics Inc.
Common Shares
2021-01-14$15.03/sh−19,581→ 0 total
Exercise/Conversion
Trillium Therapeutics Inc.
Stock Option (Right to Buy)
2021-01-14−19,581→ 1,250,000 total
Exercise/Conversion
Trillium Therapeutics Inc.
Common Shares
2021-01-14$0.43/sh+19,581→ 19,581 total
Sale
Trillium Therapeutics Inc.
Common Shares
2021-01-13$15.04/sh−5,419→ 0 total
Exercise/Conversion
Trillium Therapeutics Inc.
Common Shares
2021-01-13$0.42/sh+5,419→ 5,419 total
Exercise/Conversion
Trillium Therapeutics Inc.
Stock Option (Right to Buy)
2021-01-13−5,419→ 1,269,581 total

Companies

Recent Filings

Address

MONTE ROSA THERAPEUTICS, INC. 321 HARRISON AVENUE, SUITE 900

BOSTON, MA, 02118

View on SEC.gov